Basic Information
LncRNA/CircRNA Name | circZKSCAN1 |
Synonyms | |
Region | |
Ensemble | |
Refseq |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | bladder cancer |
ICD-0-3 | C67 |
Methods | qPCR, Biotin-coupled probe pull-down assays, FISH and luciferase reporter assays |
Sample | bladder cancer tissues and cell lines |
Expression Pattern | down-regulated |
Function Description | we found that circ-ZKSCAN1 was downregulated in BCa tissues and cell lines. Circ-ZKSCAN1 levels were associated with survival, tumor grade, pathological T stage and tumor recurrence. Overexpressed circ-ZKSCAN1 inhibits cell proliferation, migration, invasion and metastasis in vitro and in vivo. |
Pubmed ID | 31481066 |
Year | 2019 |
Title | Circular RNA circ-ZKSCAN1 Inhibits Bladder Cancer Progression Through miR-1178-3p/p21 Axis and Acts as a Prognostic Factor of Recurrence |
External Links
Links for circZKSCAN1 | GenBank HGNC NONCODE |
Links for bladder cancer | OMIM COSMIC |